ATE339502T1 - Tryptaseninhibitor - Google Patents
TryptaseninhibitorInfo
- Publication number
- ATE339502T1 ATE339502T1 AT00946166T AT00946166T ATE339502T1 AT E339502 T1 ATE339502 T1 AT E339502T1 AT 00946166 T AT00946166 T AT 00946166T AT 00946166 T AT00946166 T AT 00946166T AT E339502 T1 ATE339502 T1 AT E339502T1
- Authority
- AT
- Austria
- Prior art keywords
- proteins
- relates
- mast cell
- tryptase inhibitor
- cell tryptase
- Prior art date
Links
- 229940122598 Tryptase inhibitor Drugs 0.000 title 1
- 239000002750 tryptase inhibitor Substances 0.000 title 1
- 102000001400 Tryptase Human genes 0.000 abstract 2
- 108060005989 Tryptase Proteins 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000238876 Acari Species 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 210000003630 histaminocyte Anatomy 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 108091006086 inhibitor proteins Proteins 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Insects & Arthropods (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9916913.8A GB9916913D0 (en) | 1999-07-19 | 1999-07-19 | Inhibitor proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE339502T1 true ATE339502T1 (de) | 2006-10-15 |
Family
ID=10857516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00946166T ATE339502T1 (de) | 1999-07-19 | 2000-07-19 | Tryptaseninhibitor |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6987168B1 (de) |
| EP (1) | EP1196579B1 (de) |
| JP (1) | JP2003509014A (de) |
| CN (1) | CN100510073C (de) |
| AT (1) | ATE339502T1 (de) |
| AU (1) | AU781498B2 (de) |
| BR (1) | BR0012589A (de) |
| CA (1) | CA2379627A1 (de) |
| DE (1) | DE60030724T2 (de) |
| DK (1) | DK1196579T3 (de) |
| ES (1) | ES2272301T3 (de) |
| GB (1) | GB9916913D0 (de) |
| HK (1) | HK1042519B (de) |
| MX (1) | MXPA02000677A (de) |
| NZ (1) | NZ516809A (de) |
| PT (1) | PT1196579E (de) |
| WO (1) | WO2001005823A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9115382B2 (en) * | 2004-06-03 | 2015-08-25 | Leroy E. Mosher | Kit for detection of hemolytic Streptococcus |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5187153A (en) * | 1986-11-17 | 1993-02-16 | Scios Nova Inc. | Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
| IL104325A (en) * | 1992-01-07 | 2000-10-31 | Novo Nordisk As | Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above |
| TW492975B (en) * | 1993-07-26 | 2002-07-01 | Novartis Ag | Tryptase inhibitor |
| WO1995004750A1 (en) * | 1993-08-09 | 1995-02-16 | Athena Neurosciences, Inc. | Tick derived protease inhibitor |
| US5633227A (en) * | 1994-09-12 | 1997-05-27 | Miles, Inc. | Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
-
1999
- 1999-07-19 GB GBGB9916913.8A patent/GB9916913D0/en not_active Ceased
-
2000
- 2000-07-19 US US10/031,685 patent/US6987168B1/en not_active Expired - Fee Related
- 2000-07-19 CN CNB008127743A patent/CN100510073C/zh not_active Expired - Fee Related
- 2000-07-19 ES ES00946166T patent/ES2272301T3/es not_active Expired - Lifetime
- 2000-07-19 WO PCT/GB2000/002791 patent/WO2001005823A2/en active IP Right Grant
- 2000-07-19 DE DE60030724T patent/DE60030724T2/de not_active Expired - Fee Related
- 2000-07-19 DK DK00946166T patent/DK1196579T3/da active
- 2000-07-19 JP JP2001511480A patent/JP2003509014A/ja active Pending
- 2000-07-19 CA CA002379627A patent/CA2379627A1/en not_active Abandoned
- 2000-07-19 EP EP00946166A patent/EP1196579B1/de not_active Expired - Lifetime
- 2000-07-19 PT PT00946166T patent/PT1196579E/pt unknown
- 2000-07-19 AT AT00946166T patent/ATE339502T1/de not_active IP Right Cessation
- 2000-07-19 MX MXPA02000677A patent/MXPA02000677A/es active IP Right Grant
- 2000-07-19 AU AU60040/00A patent/AU781498B2/en not_active Ceased
- 2000-07-19 NZ NZ516809A patent/NZ516809A/en unknown
- 2000-07-19 BR BR0012589-0A patent/BR0012589A/pt not_active Application Discontinuation
-
2002
- 2002-05-15 HK HK02103668.3A patent/HK1042519B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1042519A1 (en) | 2002-08-16 |
| DE60030724D1 (en) | 2006-10-26 |
| DE60030724T2 (de) | 2007-10-04 |
| GB9916913D0 (en) | 1999-09-22 |
| EP1196579A2 (de) | 2002-04-17 |
| CN1474871A (zh) | 2004-02-11 |
| PT1196579E (pt) | 2006-12-29 |
| ES2272301T3 (es) | 2007-05-01 |
| AU6004000A (en) | 2001-02-05 |
| HK1042519B (zh) | 2007-03-09 |
| DK1196579T3 (da) | 2007-01-08 |
| WO2001005823A3 (en) | 2001-09-07 |
| BR0012589A (pt) | 2002-04-09 |
| NZ516809A (en) | 2004-05-28 |
| MXPA02000677A (es) | 2003-07-21 |
| WO2001005823A2 (en) | 2001-01-25 |
| JP2003509014A (ja) | 2003-03-11 |
| CN100510073C (zh) | 2009-07-08 |
| US6987168B1 (en) | 2006-01-17 |
| EP1196579B1 (de) | 2006-09-13 |
| AU781498B2 (en) | 2005-05-26 |
| CA2379627A1 (en) | 2001-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1202743T3 (da) | Farmaceutiske og kosmetiske sammensætninger omfattende serinproteaser fra torsk og deres farmaceutiske og kosmetiske anvendelse | |
| DE60315146D1 (de) | Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase | |
| DE60011100D1 (de) | Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen | |
| EA200401471A1 (ru) | Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов | |
| EA200101166A1 (ru) | Ингибиторы металлопротеаз | |
| DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| ATE506951T1 (de) | Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit | |
| DE60330485D1 (de) | Zur behandlung von diabetes | |
| IL162828A0 (en) | Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection | |
| ATE542804T1 (de) | 5-phenyl-pentansäurederivate als matrixmetalloproteinase-inhibitoren zur behandlung von asthma und anderen erkrankungen | |
| ATE333451T1 (de) | Verwendung von nitrilenverbindungen als arztneimittel | |
| DE112004000961D2 (de) | Verwendung von Wirksubstanzen zur Vorbeugung oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen | |
| DK1401413T3 (da) | Anvendelse af tyrosinkinaseinhibitorer til behandling af allergiske sygdomme | |
| ATE399011T1 (de) | Substituierte diketopiperazine als oxytocin- antagonisten | |
| DK1401416T5 (da) | Anvendelse af C-kit-inhibitorer til behandling af inflammatorisk tarmsygdom | |
| IS5956A (is) | Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla | |
| MX9702776A (es) | Proteinas de proteasa de pulgas, moleculas de acido nucleico, y usos de las mismas. | |
| DE60313803D1 (de) | Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen | |
| DK1196579T3 (da) | Tryptaseinhibitor | |
| DE602004009414D1 (de) | BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN MIT N-2,3,3-TETRAMETHYLBICYCLOi2.2.1öHEPTAN-2-AMINE | |
| DE60209886D1 (de) | Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen | |
| DE60325275D1 (de) | Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen | |
| DE10193322D2 (de) | Verwendung von Protonenpumpen-Hemmern zur Behandlung von Erkrankungen des Bewegungsapparates | |
| ATE390144T1 (de) | Behandlung von fibrosen | |
| AU9683401A (en) | Flea peritrophin nucleic acid molecules, proteins and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1196579 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |